Results 201 to 210 of about 291,220 (220)

Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics

Platelets
Although there have been tremendous improvements in the production and storage of platelets, platelet transfusion refractoriness (PTR) remains a serious clinical issue that may lead to various severe adverse events.
Jue Xie, Yan Lv, Xiaoyu Chen
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management

Blood Reviews, 2023
Sandhya R Panch
exaly  

Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases

Platelets, 2023
Yue Han
exaly  

Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion

Transfusion Medicine Reviews, 2020
Roger Belizaire
exaly  

Top bar navigation

Frontiers in Immunology, 2023
Blandine Maître
exaly  

Platelet transfusion: Alloimmunization and refractoriness

Seminars in Hematology, 2020
Michael Murphy, Alexandros Rampotas, Simon Stanworth   +2 more
exaly  

Platelet transfusion refractoriness

British Journal of Haematology, 2008
Eldad A Hod, Joseph E. Schwartz
exaly  

The definition of refractoriness to platelet transfusions

Transfusion Medicine, 1992
Kally Yuen, M M Wolf, J P Matthews
exaly  

Severe Platelet Transfusion Refractoriness in Association with Antibodies Against CD36

Laboratory Medicine, 2020
Majed A Refaai, Amy E Schmidt
exaly  

Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome

Platelets, 2015
Yu-Hong Zhou
exaly